Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics

Advances in disease-related gene discovery have led to tremendous innovations in the field of epilepsy genetics. Identification of genetic mutations that cause epileptic encephalopathies has opened new avenues for the development of targeted therapies. Clinical testing using extensive gene panels, e...

Full description

Saved in:
Bibliographic Details
Published in:Children (Basel) 2023-03, Vol.10 (3), p.556
Main Authors: Chang, Yu-Tzu, Hong, Syuan-Yu, Lin, Wei-De, Lin, Chien-Heng, Lin, Sheng-Shing, Tsai, Fuu-Jen, Chou, I-Ching
Format: Article
Language:English
Subjects:
Congenital diseases
Convulsions & seizures
developmental delay
Disease
Encephalopathy
Epilepsy
epileptic encephalopathy
Genes
Genetic aspects
Genetic screening
Genetic testing
Genetics
Genomes
Genomics
Intellectual disabilities
Laboratories
Metabolism
Methods
Mutation
next-generation sequencing
Patients
Pediatric research
Precision medicine
Review
whole-genome sequencing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Advances in disease-related gene discovery have led to tremendous innovations in the field of epilepsy genetics. Identification of genetic mutations that cause epileptic encephalopathies has opened new avenues for the development of targeted therapies. Clinical testing using extensive gene panels, exomes, and genomes is currently accessible and has resulted in higher rates of diagnosis and better comprehension of the disease mechanisms underlying the condition. Children with developmental disabilities have a higher risk of developing epilepsy. As our understanding of the mechanisms underlying encephalopathies and epilepsies improves, there may be greater potential to develop innovative therapies tailored to an individual's genotype. This article provides an overview of the significant progress in epilepsy genomics in recent years, with a focus on developmental and epileptic encephalopathies in children. The aim of this review is to enhance comprehension of the clinical utilization of genetic testing in this particular patient population. The development of effective and precise therapeutic strategies for epileptic encephalopathies may be facilitated by a comprehensive understanding of their molecular pathogenesis.
ISSN:2227-9067
2227-9067
DOI:10.3390/children10030556